Isis Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2009.
2009 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Isis Drugs Private Limited

Isis Drugs Private Limited, a struck off private limited company, was established on 07 September 2009 in Mumbai, Maharashtra, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100MH2009PTC195558. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shashikant Pagar (Director), Avinash Pardhi (Director). It is based at 13/A-405, Dwarkamai C.H.S. Saiwadi Andheri East, Mumbai, Maharashtra, 400069.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2009PTC195558

  • Registration Number

    195558

  • Incorporation Date

    07 September 2009

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 5 Months
Company report

Isis Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Isis Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Isis Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Shashikant Pagar Director 07 Sep 2009 Current
Avinash Pardhi Director 07 Sep 2009 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Isis Drugs.

Enhance accessibility to Isis Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Isis Drugs revenue growth over time
Isis Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Isis Drugs?

Unlock access to Isis Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Isis Drugs?

Unlock and access historical data on people associated with Isis Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Isis Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Isis Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Isis Drugs
Recent Activity within the Organization
  • Director Appointment

    The activity Shashikant Pagar was appointed as a Director was appointed as a Director on 07 Sep 2009 & has been associated with this company since 16 years 5 months . was completed.

  • Director Appointment

    The activity Avinash Pardhi was appointed as a Director was appointed as a Director on 07 Sep 2009 & has been associated with this company since 16 years 5 months . was completed.

  • Company Incorporation

    Progress on Isis Drugs Private Limited was registered on 07 Sep 2009 with Roc Mumbai & aged 16 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Isis Drugs Private Limited?

The CIN of Isis Drugs Private Limited is U24100MH2009PTC195558.

Where is Isis Drugs Private Limited headquartered?

Isis Drugs Private Limited is headquartered at 13/A-405, Dwarkamai C.H.S. Saiwadi Andheri East, Mumbai, Maharashtra, 400069.

When was Isis Drugs Private Limited incorporated?

Isis Drugs Private Limited was incorporated on 07 September 2009.

Who are the current directors of Isis Drugs Private Limited?

The current directors of Isis Drugs Private Limited are

What is the primary industry of Isis Drugs Private Limited?

The primary industry of Isis Drugs Private Limited is Chemicals.

Is Isis Drugs Private Limited a listed company?

Isis Drugs Private Limited is unlisted.

What is the capital structure of Isis Drugs Private Limited?

The authorized capital of Isis Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available